Extracellular dna as a therapeutic target in neurodegeneration
AssigneeCLS Therapeutics Limited
InventorsDmitry Dmitrievich GENKIN, Georgy Viktorovich TETS, Viktor Veniaminovich TETS
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of deoxyribonuclease (DNase) enzyme for inhibiting progression and for prevention and treatment of neurodegeneration.
Claims43
A method for preventing, treating and/or inhibiting progression of neurodegeneration in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a DNase enzyme.
(canceled)
A pharmaceutical composition comprising a DNase enzyme for use in a method of preventing, treating and/or inhibiting progression of neurodegeneration, wherein said neurodegeneration is associated with an increased level of extracellular DNA in blood or cerebrospinal fluid or intestine.
(canceled)
43-89. (canceled)
Dependencies are inferred from the claim text.